Department of Molecular Medicine and Biotechnology, School of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20467-72. doi: 10.1073/pnas.1218535109. Epub 2012 Nov 20.
Impairment of ribosomal biogenesis can activate the p53 protein independently of DNA damage. The ability of ribosomal proteins L5, L11, L23, L26, or S7 to bind Mdm2 and inhibit its ubiquitin ligase activity has been suggested as a critical step in p53 activation under these conditions. Here, we report that L5 and L11 are particularly important for this response. Whereas several other newly synthesized ribosomal proteins are degraded by proteasomes upon inhibition of Pol I activity by actinomycin D, L5 and L11 accumulate in the ribosome-free fraction where they bind to Mdm2. This selective accumulation of free L5 and L11 is due to their mutual protection from proteasomal degradation. Furthermore, the endogenous, newly synthesized L5 and L11 continue to be imported into nucleoli even after nucleolar disruption and colocalize with Mdm2, p53, and promyelocytic leukemia protein. This suggests that the disrupted nucleoli may provide a platform for L5- and L11-dependent p53 activation, implying a role for the nucleolus in p53 activation by ribosomal biogenesis stress. These findings may have important implications with respect to understanding the pathogenesis of diseases caused by impaired ribosome biogenesis.
核糖体生物发生的损伤可独立于 DNA 损伤激活 p53 蛋白。核糖体蛋白 L5、L11、L23、L26 或 S7 结合 Mdm2 并抑制其泛素连接酶活性的能力被认为是在这些条件下 p53 激活的关键步骤。在这里,我们报告 L5 和 L11 对此反应尤为重要。虽然几种其他新合成的核糖体蛋白在放线菌素 D 抑制 Pol I 活性时被蛋白酶体降解,但 L5 和 L11 在核糖体游离部分积累,在那里它们与 Mdm2 结合。这种游离 L5 和 L11 的选择性积累是由于它们相互保护免受蛋白酶体降解。此外,即使在核仁破坏后,内源性新合成的 L5 和 L11 仍继续被导入核仁,并与 Mdm2、p53 和早幼粒细胞白血病蛋白共定位。这表明受损的核仁可能为 L5 和 L11 依赖性 p53 激活提供了一个平台,暗示核仁在核糖体生物发生应激诱导的 p53 激活中发挥作用。这些发现可能对理解由核糖体生物发生受损引起的疾病的发病机制具有重要意义。